One-month atogepant treatment induces rapid changes in delta-band functional connectivity in migraine: an HD-EEG study

Abstract Background Atogepant is a novel oral calcitonin gene-related peptide (CGRP) receptor antagonist approved for the preventive treatment of migraine. While its peripheral mechanisms are well characterized, little is known about its potential effects on central functional brain networks. This s...

Full description

Bibliographic Details

Published in:	The Journal of Headache and Pain
Main Authors:	Matteo Conti, Silvio Bagetta, Federico Carparelli, Valerio Ferrari, Vittoria Carla D’Agostino, Fabio Placidi, Alessandro Stefani, Nicola Biagio Mercuri, Maria Albanese
Format:	Article
Language:	English
Published:	BMC 2025-07-01
Subjects:	Migraine Atogepant HD-EEG Functional connectivity
Online Access:	https://doi.org/10.1186/s10194-025-02115-y